000 01247 a2200325 4500
005 20250516205345.0
264 0 _c20150112
008 201501s 0 0 eng d
022 _a1549-490X
024 7 _a10.1634/theoncologist.2014-038
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohnston, Patrick G
245 0 0 _aIdentification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new era.
_h[electronic resource]
260 _bThe oncologist
_cMay 2014
300 _a568-73 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aColorectal Neoplasms
_xclassification
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aMolecular Medicine
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aProto-Oncogene Proteins p21(ras)
650 0 4 _aras Proteins
_xgenetics
773 0 _tThe oncologist
_gvol. 19
_gno. 5
_gp. 568-73
856 4 0 _uhttps://doi.org/10.1634/theoncologist.2014-038
_zAvailable from publisher's website
999 _c23723943
_d23723943